PE20040084A1 - DRUG COMBINATIONS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTICHOLINERGIC AGENT - Google Patents
DRUG COMBINATIONS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTICHOLINERGIC AGENTInfo
- Publication number
- PE20040084A1 PE20040084A1 PE2003000366A PE2003000366A PE20040084A1 PE 20040084 A1 PE20040084 A1 PE 20040084A1 PE 2003000366 A PE2003000366 A PE 2003000366A PE 2003000366 A PE2003000366 A PE 2003000366A PE 20040084 A1 PE20040084 A1 PE 20040084A1
- Authority
- PE
- Peru
- Prior art keywords
- phenyl
- ethyl
- containing heterocyclic
- heterocyclic compounds
- drug combinations
- Prior art date
Links
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 title 1
- 239000000812 cholinergic antagonist Substances 0.000 title 1
- 239000000890 drug combination Substances 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- -1 n-BUTYL Chemical class 0.000 abstract 7
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 3
- 125000001495 ethyl group Chemical class [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 abstract 2
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical class CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 abstract 1
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 abstract 1
- 229910002651 NO3 Inorganic materials 0.000 abstract 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 abstract 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 210000002345 respiratory system Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UNA SAL DE FORMULA I DONDE X- ES UN ANION MONOCARGADO NEGATIVAMENTE SELECCIONADO DEL GRUPO DE Cl, Br, I, METANOSULFONATO, NITRATO, MALEATO, FUMARATO ENTRE OTROS EN COMBINACION CON UN COMPUESTO DE FORMULA II DONDE R1 ES H, METILO, ETILO, n-BUTILO, i-BUTILO, FENILO, 2-ETILFENILO, BENCILO, ENTRE OTROS; R2 ES H, METILO, ETILO O JUNTO CON R1, UN PUENTE BUTILENO O PENTILENO; R3 ES H; R4 ES METOXI; R5 ES CICLOHEXILO, FENILO, 3-METOXICARBONILFENILO, 4-METOXICARBONILFENILO, 3-CARBOXIFENILO, 4-CARBOXIFENILO, CN, -COOH, ENTRE OTROS; A ES O, -CH2-; B ES O, -C(R12)(R13)-, ENTRE OTROS; D ES -CH2-CH2-, -CH(Ph)-CH2-, -CONH-, -CO-CH2, ENTRE OTROS; R12 ES H, METILO, ETILO, I-PROPILO, FENILO ENTRE OTROS; R13 ES H O, JUNTO CON R2, UN ENLACE SENCILLO O UN PUENTE BUTILENO. LA COMBINACION MENCIONADA PUEDE ESTAR CONTENIDA EN UNA UNICA FORMA DE ADMINISTRACION O EN DOS FORMAS DE ADMINISTRACION SEPARADAS Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIASREFERS TO A SALT OF FORMULA I WHERE X- IS A MONOCHARGED ANION NEGATIVELY SELECTED FROM THE GROUP OF Cl, Br, I, METHANOSULPHONATE, NITRATE, MALEATE, FUMARATE AMONG OTHERS IN COMBINATION WITH A COMPOUND OF FORMULA II, WHERE R1 IS ME ETHYL, n-BUTYL, i-BUTYL, PHENYL, 2-ETHYLPHENYL, BENZYL, AMONG OTHERS; R2 IS H, METHYL, ETHYL OR, TOGETHER WITH R1, A BUTYLENE OR PENTILENE BRIDGE; R3 IS H; R4 IS METHOXY; R5 IS CYCLOHEXYL, PHENYL, 3-METHOXICARBONYLPHENYL, 4-METOXICARBONYLPHENYL, 3-CARBOXYPHENYL, 4-CARBOXYPHENYL, CN, -COOH, AMONG OTHERS; A IS O, -CH2-; B IS O, -C (R12) (R13) -, AMONG OTHERS; D IS -CH2-CH2-, -CH (Ph) -CH2-, -CONH-, -CO-CH2, AMONG OTHERS; R12 IS H, METHYL, ETHYL, I-PROPYL, PHENYL, AMONG OTHERS; R13 IS H O, TOGETHER WITH R2, A SIMPLE LINK OR A BUTYLENE BRIDGE. THE MENTIONED COMBINATION MAY BE CONTAINED IN A SINGLE FORM OF ADMINISTRATION OR IN TWO SEPARATE FORMS OF ADMINISTRATION AND ARE USEFUL FOR THE TREATMENT OF DISEASES OF THE RESPIRATORY TRACT
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10216427A DE10216427A1 (en) | 2002-04-12 | 2002-04-12 | Pharmaceutical compositions containing heterocyclic compounds and a new anticholinergic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20040084A1 true PE20040084A1 (en) | 2004-04-01 |
Family
ID=28458800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2003000366A PE20040084A1 (en) | 2002-04-12 | 2003-04-10 | DRUG COMBINATIONS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTICHOLINERGIC AGENT |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20040002502A1 (en) |
| AR (1) | AR039404A1 (en) |
| AU (1) | AU2003221562A1 (en) |
| DE (1) | DE10216427A1 (en) |
| PE (1) | PE20040084A1 (en) |
| TW (1) | TW200406209A (en) |
| UY (1) | UY27759A1 (en) |
| WO (1) | WO2003087049A2 (en) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7417051B2 (en) * | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
| US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
| US20040044020A1 (en) * | 2002-07-09 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors |
| US20040048887A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors |
| US20040058950A1 (en) * | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| US20040048886A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists |
| US20040166065A1 (en) * | 2002-08-14 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation comprising an anticholinergic |
| US7244742B2 (en) * | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| US8398820B2 (en) | 2002-10-07 | 2013-03-19 | Georgia-Pacific Consumer Products Lp | Method of making a belt-creped absorbent cellulosic sheet |
| US7494563B2 (en) | 2002-10-07 | 2009-02-24 | Georgia-Pacific Consumer Products Lp | Fabric creped absorbent sheet with variable local basis weight |
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US7332175B2 (en) * | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
| EP1504756A1 (en) * | 2003-08-06 | 2005-02-09 | Kyowa Hakko Kogyo Co., Ltd | Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| DE10345065A1 (en) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
| US20050272726A1 (en) * | 2004-04-22 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Novel medicaments for the treatment of respiratory diseases |
| US7220742B2 (en) * | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| MX2008001976A (en) * | 2005-08-15 | 2008-03-25 | Boehringer Ingelheim Int | Method for producing betamimetics. |
| US7599861B2 (en) | 2006-03-02 | 2009-10-06 | Convergys Customer Management Group, Inc. | System and method for closed loop decisionmaking in an automated care system |
| US7809663B1 (en) | 2006-05-22 | 2010-10-05 | Convergys Cmg Utah, Inc. | System and method for supporting the utilization of machine language |
| US8379830B1 (en) | 2006-05-22 | 2013-02-19 | Convergys Customer Management Delaware Llc | System and method for automated customer service with contingent live interaction |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2540633A1 (en) * | 1975-09-12 | 1977-04-28 | Boehringer Sohn Ingelheim | NEW QUARTERLY N-BETA-SUBSTITUTED BENZILIC ACID-N-ALKYL-NORTROPINESTER AND PROCESS FOR THE PREPARATION |
| US5770738A (en) * | 1992-03-05 | 1998-06-23 | Boehringer Ingelheim Kg | Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions |
| EP0771794B1 (en) * | 1995-05-19 | 2006-05-03 | Kyowa Hakko Kogyo Co., Ltd. | Oxygen-containing heterocyclic compounds |
| DE19921693A1 (en) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects |
| US6706726B2 (en) * | 2000-10-14 | 2004-03-16 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics which may be used as medicaments as well as processes for preparing them |
| US20020193393A1 (en) * | 2001-03-07 | 2002-12-19 | Michel Pairet | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| DE10200943A1 (en) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Process for the preparation of scopine esters |
| US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
| US7417051B2 (en) * | 2002-04-12 | 2008-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising betamimetics and a novel anticholinergic |
| US20040048887A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors |
| US20040058950A1 (en) * | 2002-07-09 | 2004-03-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors |
| US20040044020A1 (en) * | 2002-07-09 | 2004-03-04 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors |
| US20040048886A1 (en) * | 2002-07-09 | 2004-03-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists |
| US20040166065A1 (en) * | 2002-08-14 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation comprising an anticholinergic |
| US7244742B2 (en) * | 2002-08-17 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co Kg | Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic |
| US7332175B2 (en) * | 2003-05-27 | 2008-02-19 | Boehringer Ingelheim International Gmbh | Long-acting drug combinations for the treatment of respiratory complaints |
| US7273603B2 (en) * | 2003-07-11 | 2007-09-25 | Boehringer Ingelheim International Gmbh | HFC solution formulations containing an anticholinergic |
| TWI259994B (en) * | 2003-07-21 | 2006-08-11 | Ali Corp | Adaptive multiple levels step-sized method for time scaling |
| DE10345065A1 (en) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation containing an anticholinergic |
| US20050154006A1 (en) * | 2004-01-09 | 2005-07-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on a scopineester and nicotinamide derivatives |
| US20050186175A1 (en) * | 2004-02-20 | 2005-08-25 | Boehringer Ingelheim International Gmbh | Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins |
-
2002
- 2002-04-12 DE DE10216427A patent/DE10216427A1/en not_active Withdrawn
-
2003
- 2003-04-08 US US10/409,402 patent/US20040002502A1/en not_active Abandoned
- 2003-04-09 WO PCT/EP2003/003670 patent/WO2003087049A2/en not_active Ceased
- 2003-04-09 AU AU2003221562A patent/AU2003221562A1/en not_active Abandoned
- 2003-04-10 UY UY27759A patent/UY27759A1/en not_active Application Discontinuation
- 2003-04-10 TW TW092108228A patent/TW200406209A/en unknown
- 2003-04-10 PE PE2003000366A patent/PE20040084A1/en not_active Application Discontinuation
- 2003-04-11 AR ARP030101265A patent/AR039404A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200406209A (en) | 2004-05-01 |
| AU2003221562A1 (en) | 2003-10-27 |
| WO2003087049A3 (en) | 2004-02-05 |
| WO2003087049A2 (en) | 2003-10-23 |
| AU2003221562A8 (en) | 2003-10-27 |
| UY27759A1 (en) | 2003-11-28 |
| AR039404A1 (en) | 2005-02-16 |
| US20040002502A1 (en) | 2004-01-01 |
| DE10216427A1 (en) | 2003-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20040084A1 (en) | DRUG COMBINATIONS CONTAINING HETEROCYCLIC COMPOUNDS AND A NEW ANTICHOLINERGIC AGENT | |
| AR055669A1 (en) | DERIVATIVES OF 3H - IMIDAZO [4, 5 -B] PIRIDINE AS SELECTIVE INHIBITORS OF GSK3, METHODS AND INTERNEDIARIES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF NEURODE DISEASE. | |
| ECSP105253A (en) | DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS INHIBITORS OF PI3 CINASA | |
| HUP0400365A2 (en) | 3-fluoro-pyrrolidines as antidiabetic agents and pharmaceutical compositions containing the compounds | |
| EP1867649A4 (en) | PIPERIDYL-2,6-DIONE DERIVATIVES FOR PREVENTING CELLS FROM RELEASING TUMOR NECROSIS FACTOR | |
| CO5611172A2 (en) | STENTS COVERED WITH N- {5- [4- (4-METHYL-PIPERAZINO-METHYL) -BENOZYLAMIDE] -2-METHYLPENYL} -4- (3-PIRIDIL) -2-PIRIMIDIN-AMINA | |
| DK1697371T3 (en) | Azabicyclic heterocyclic compounds as cannabinoid receptor modulators | |
| AR072900A1 (en) | THERAPEUTIC AGENTS DERIVED FROM PIRAZOLO [3,4-D] PYRIMIDINE | |
| RU2008143703A (en) | The use of c-Src inhibitors in combination with pyrimidylamine benzamide for the treatment of leukemia | |
| NO20050569L (en) | Procedure for the treatment of severe heart failure and drug for this | |
| EA200601846A1 (en) | CONTAINING BENZOXASINS MEDICINAL COMBINATIONS FOR THE TREATMENT OF DISEASES OF RESPIRATORY TRACKS | |
| DK1458393T3 (en) | Substituted diketopiperazines as oxytocin antagonists | |
| ATE361918T1 (en) | 4-(4-METHOXYBENZYL)-N'-(5-NITRO-1,3-THIAZOL-2-YL)UREA AND ITS USE IN THE TREATMENT OF GLYCOGEN SYNTHASE KINASE-3 (GSK3)-ASSOCIATED CONDITIONS | |
| AR057554A1 (en) | CARBAMOILBENZOTRIAZOL DERIVATIVES AS INHIBITORS OF LIPASES AND PHOSPHOLIPASES | |
| EA200870089A1 (en) | APPLICATION OF DERIVATIVES OF BENZEN-CONDENSED HETEROCYCLIC SULFAMIDE FOR THE TREATMENT OF ABUSE OF PSYCHOACTIVE SUBSTANCE AND ADDICTION | |
| AR038824A1 (en) | COMPOSITIONS OF DRUGS THAT, TOGETHER WITH COLINERGIC AGENTS, CONTAIN HETEROCICLICAL COMPOUNDS | |
| EA200601249A1 (en) | PIPERASINS, SUITABLE FOR THE TREATMENT OF PAIN | |
| DK1696922T3 (en) | Use of a hydroxymic acid halide derivative for the treatment of neurodegenerative diseases | |
| DK1656131T3 (en) | Use of betaine to treat claudicatio intermittens | |
| AR050711A1 (en) | ARILSULFONYLESTILBEN DERIVATIVES FOR THE TREATMENT AND / OR PREVENTION OF AFFECTIONS OF THE CENTRAL NERVOUS SYSTEM | |
| ATE444069T1 (en) | QUINOLINE DERIVATIVES FOR THE TREATMENT OF MGLUR5 RECEPTOR-MEDIATED DISEASES | |
| DE602006020666D1 (en) | Methods and compositions for calming the oral and nasal mucous membranes | |
| RU2004126145A (en) | N - {[((2S) -4- (3,4-DIFLUORBENZENE) MORPHOLIN-2YL] -METHyl} -2- {3- [(METHYLSULPHONYL) AMINO] PHENIES L} ACETAMIDE AS A TREATMENT TREATMENT CCR-3 FOR TREATMENT | |
| DE60211938D1 (en) | PHARMACEUTICAL PREPARATION CONTAINING A COMBINATION OF METFORMIN AND A 4-OXOBUTANONIC ACIDS AND THEIR USE FOR THE TREATMENT OF DIABETES | |
| BRPI0512151A (en) | concentrated solution of tenatoprazole monohydrate sodium salt, pharmaceutical composition, use of tenatoprazole monohydrate sodium salt, preparation process of tenatoprazole monohydrate sodium salt, and composition for oral administration of tenatoprazole monohydrate sodium salt |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |